Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

Ikarovec Ltd.

Established in 2019, Ikarovec is developing novel, differentiated gene therapies for major ophthalmic indications. Its lead product, a multicistronic gene therapy for diabetic macular edema, is in preclinical studies, and earlier programmes are targeting wet age-related macular degeneration (AMD), dry AMD and intraocular hypertension. Building on intellectual property spun-out of Quethera (bought by Astellas in 2018), Ikarovec was founded by UKI2S and recently raised a £2.5m seed round with co-funding from LifeArc and Parkwalk Advisers. There is an experienced senior management team in place with business development and commercial success in ophthalmology and gene therapy - Dr Peter Widdowson (ex Quethera) is Founder and Chief Scientific Officer, and Dr Robert Haigh (ex KalVista) is Executive Chairman. *

 

Period Start 2018-08-07 established (s-off)
  Predecessor Quethera Ltd.
Products Industry gene therapy eye disease
  Industry 2 ophthalmic
Persons Person Haigh, Robert (Macomics 202007– CEO + Executive Chair of Ikarovec before Ferring + Boehringer Ingelheim)
  Person 2 Widdowson, Peter S. (Quethera 201808 CEO)
     
Region Region Norwich, Norfolk
  Country United Kingdom (GB)
  Street Colney Lane
Norwich Research Park, Innovation Centre
  City Norwich, Norfolk
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Ikarovec Ltd.. (2/5/20). "Press Release: Ophthalmic Gene Therapy Company Ikarovec Launches with £2.5m Seed Funding". Cambridge.
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Ikarovec Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top